ELAVL1 and inflammatory bowel disease: Consistent with findings observed in IBD patients without SC (Xiao et al, 2019), the ileal mucosa from patients with CD/SC also exhibited a significant decrease in the levels of HuR (Fig 3A), as measured by immunostaining analysis.